Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

NervGen Pharma: A “Blockbuster Drug” in the Making?

It has the potential to be one of the most disruptive pharmaceutical drug therapies of the modern era, especially for treating Alzheimer’s disease. And that gives it considerable “blockbuster drug” potential – a tantalising opportunity tha...
Marc Davis | June 25, 2021 |

The S&P 500 Bull Keeps Climbing the Wall of Worry

How close to its end is this S&P 500 consolidation are we – will the rebound meet its spark? Yesterday's session carries signs of the upcoming move, which I think will be higher. As said yesterday – in the battle of narratives, the corona second wave fears still play second fi...
Monica Kingsley | June 19, 2020 |

How Much Lost Ground Can the S&P 500 Bulls Recover?

Stocks couldn’t build on Wednesday’s gains, and the bulls had to face selling pressure during yesterday’s regular session. While they’ve dealt with a good part of the intraday downswing, they couldn&CloseCurlyQuot...
Monica Kingsley | May 1, 2020 |

Cracking the Code to Society’s Most Feared Disease

Even more so than cancer, it’s the one disease that we all fear the most. The thought of falling prey to Alzheimer’s disease and to the inevitable desecration of our mind is something that makes even the bravest among us shudder. ...
Marc Davis | February 7, 2020 |

The Oil Bears Punished the Bulls’ Hesitation. What Now?

Oil has decidedly moved yesterday, and the closing price didn’t make the bulls happy. They haven’t had much success repairing the damage earlier today, though. Does it mean that the bears can set their sights even lower now? Can geopolitical eve...
Nadia Simmons | July 17, 2019 |

Subliminal Capitulation

Looking back at the events of last week, the S&P 500 finally took out the October highs at 2,941 intraday, making the 2018 bear market one of the shortest on record at 93 days (Sept. 21–Dec. 24). You will recall that I wrote in early January that the action of the Santa C...
Streetwise Reports | May 8, 2019 |